Clinical Trials on Corona Virus Disease 2019(COVID-19) in United Kingdom

Total 2088 results

AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Murdoch Childrens Research Institute
Bill and Melinda Gates Foundation; Royal Children's Hospital

Completed

BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)

COVID-19 | Corona Virus Infection | Coronavirus Disease 2019 (COVID-19) | Respiratory Illness

Australia, Brazil, Netherlands, Spain, United Kingdom
Chelsea and Westminster NHS Foundation Trust

Recruiting

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs (PHENOTYPE)

COVID-19 | Corona Virus Infection | Coronavirus | 2019 Novel Coronavirus Infection | 2019nCoV

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Unknown

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID)

COVID-19 | COVID-19 Infection | 2019 Novel Coronavirus Infection

United Kingdom
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
CSL Behring

Completed

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
Coventry University

Completed

Cardiovascular Function and Physical Activity in COVID-19 (CV-COVID)

Coronavirus 2019

United Kingdom
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

COVID-19 (Coronavirus Disease 2019)

United States
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates
Kanecia Obie Zimmerman

Enrolling by invitation

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) (RECOVER-AUTO)

Long COVID | Long Covid-19 | Long Coronavirus Disease 2019 (Covid19)

United States
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
VA Office of Research and Development
Mayo Clinic

Completed

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

Coronavirus Disease 2019 (COVID-19)

United States
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Theravance Biopharma

Completed

TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...
Boston Children's Hospital; Benaroya Research Institute

Completed

Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)

SARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.

Completed

COVID-19: Human Epidemiology and Response to SARS-CoV-2 (HEROS)

SARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)

United States
Bayer

Completed

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib (ROCURS)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection | Malignant Solid Tumors

United States
Humanigen, Inc.

Active, not recruiting

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Coronavirus Disease 2019 (COVID-19) Pneumonia

United States, Brazil
King's College London

Completed

A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic (SWitCh)

COVID

United Kingdom
Barts & The London NHS Trust
Queen Mary University of London

Completed

Patient Recovery From Heart Surgery During the Covid-19 Pandemic (CardiacCovid)

COVID | Cardiac Surgery

United Kingdom
ProgenaBiome

Recruiting

A Study to Explore the Role of Gut Flora in COVID-19 Infection

Coronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19

United States
Resolve Therapeutics

Active, not recruiting

Phase 2 Study of RSLV-132 in Subjects With Long COVID

Post-acute Corona Virus 19 (COVID-19) (Long COVID)

United States
University of Oxford
University of Nottingham; Imperial College London; Public Health England; University... and other collaborators

Unknown

Neonatal Complications of Coronavirus Disease (COVID-19)

Neonatal COVID-19 Disease

United Kingdom
Nektar Therapeutics

Completed

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Covid-19 | Coronavirus Disease 2019

United States
King's College London
Zoe Global Limited; Department of Health, United Kingdom

Recruiting

Testing the Accuracy of a Digital Test to Diagnose Covid-19

Covid-19

United Kingdom
Aarogyam UK
University of Warwick; Igor Sikorsky Kyiv Polytechnic Institute; ClickMedix LLC

Completed

AiM COVID for Covid 19 Tracking and Prediction

COVID 19

United Kingdom
AstraZeneca
The Chancellor, Masters and Scholars of the University of Oxford

Completed

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England (RAVEN)

Covid-19 Infection

United Kingdom
British Ayurvedic Medical Council
University of Warwick; All Party Parliamentary Group - Indian Traditional Sciences

Withdrawn

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

Covid-19

United Kingdom
Barts & The London NHS Trust

Recruiting

3D Printed Mask Adapter Designed From Facial 3D Scans for Fit Testing.

COVID-19 Pandemic

United Kingdom
Imperial College London
Imperial College Healthcare NHS Trust

Completed

ENO Breathe vs Usual Care in COVID-19 Recovery (SHIELD ENO)

COVID-19 Recovery

United Kingdom
Medway Primary Care Trust

Completed

Surgical Consent During the COVID-19 Pandemic

Consent

United Kingdom
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
Target PharmaSolutions, Inc.

Recruiting

An Observational Study of Patients With Coronavirus Disease 2019 (COVID-19)

COVID-19 | Coronavirus

United States
The Methodist Hospital Research Institute

Unknown

Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

Covid19

United States
University Hospitals Coventry and Warwickshire...
Immunic AG; University of Warwick; MODEPHARMA

Completed

IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC)

Covid 19

United Kingdom
Ancon Technologies Ltd

Completed

Covid-19 Breath Test

Covid-19 Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...
PPD; University of Washington; Vanderbilt University Medical Center; Implicit Bioscience

Terminated

COVID-19 and Anti-CD14 Treatment Trial (CaTT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)

United States
University of South Alabama

Terminated

Trial of Hydroxychloroquine In Covid-19 Kinetics (THICK)

Corona Virus Infection | Covid 19

United States
Sheffield Hallam University
Symprove UK; Biomesight

Recruiting

Investigation of the Use of a Probiotic Supplement in People With Long COVID

Long COVID

United Kingdom
Emory University
National Cancer Institute (NCI)

Terminated

Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19)

Pneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) Pneumonia

United States
University of Pennsylvania
University of Arizona; Jordana B. Cohen, MD, MSCE; Thomas C. Hanff, MD, MPH; Department... and other collaborators

Completed

Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID)

COVID-19

United States
University of Arizona
Senhwa Biosciences, Inc.

Terminated

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) (CX4945)

Coronavirus

United States
Duke University
Novartis Pharmaceuticals

Completed

Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 (PARACOR-19)

Covid19

United States
CytoDyn, Inc.
Amarex Clinical Research

Completed

Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19

Coronavirus Disease 2019

United States

Clinical Trials on Corona Virus Disease 2019(COVID-19) in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations